CTL (n=85) | BAV (n=79) | P values | |
Age (years) | 28 (24–31) | 38 (29–51) | <0.0001 |
Men, n (%) | 37 (44) | 52 (66) | 0.004 |
Weight (kg) | 67.1 (57.5–80.6) | 73.1 (64.3–84.0) | 0.046 |
Height (m) | 1.70±0.09 | 1.71±0.10 | 0.48 |
BSA (m²) | 1.81±0.22 | 1.86±0.21 | 0.13 |
BMI (kg/m2) | 23.5 (21.3–26.4) | 25.4 (22.8–27.7) | 0.01 |
NYHA class III or IV, n (%) | 0 (0) | 1 (1) | – |
ICD, n (%) | 0 (0) | 0 (0) | – |
Oral anticoagulation, n (%) | 0 (0) | 4 (5) | – |
LVEDV (mL) | 144.5 (127.8–168.7) | 163.0 (133.3–204.2) | 0.03 |
LVESV (mL) | 47.4 (38.4–56.3) | 53.0 (40.7–80.7) | 0.03 |
LVEDVi (mL/m²) | 81.9 (75.2–87.6) | 86.3 (74.0–101.8) | 0.07 |
LVESVi (mL/m²) | 26.0 (23.2–30.6) | 30.3 (22.2–41.2) | 0.02 |
LVSV (mL) | 99.5 (86.6–111.4) | 108.0 (86.8–123.0) | 0.12 |
LVSVi (mL/m²) | 55.3 (50.6–60.1) | 55.8 (49.6–65.0) | 0.50 |
LVCO (L/min) | 6.9 (5.8–8.2) | 7.4 (6.2–8.5) | 0.37 |
LVEF (%) | 68 (64–71) | 65 (59–72) | 0.08 |
LVM (g) | 108.2 (93.0–132.1) | 131.5 (97.6–165.5) | 0.02 |
LVMi (g/m²) | 61.1 (53.9–69.5) | 71.7 (58.9–81.4) | 0.001 |
Continuous variables are expressed as mean±SD or median (25th percentile-75th percentile). Categorical variables as n (%).
BAV, bicuspid aortic valve; BMI, body mass index; BSA, body surface area; CTL, control subjects; ICD, implanted cardioverter-defibrillator; LVCO, left ventricle cardiac output; LVEDV, left ventricle end-diastolic volume; LVEDVi, LVEDV indexed by BSA; LVEF, left ventricle ejection fraction; LVESV, left ventricle end-systolic volume; LVESVi, LVESV indexed by BSA; LVM, left ventricle mass; LVMi, LVM indexed by BSA; LVSV, left ventricle stroke volume;NYHA, New York Heart Association.